MCID: PNL014
MIFTS: 40

Pineal Gland Cancer

Categories: Cancer diseases, Endocrine diseases, Neuronal diseases

Aliases & Classifications for Pineal Gland Cancer

MalaCards integrated aliases for Pineal Gland Cancer:

Name: Pineal Gland Cancer 12 15
Tumor of the Pineal Region 12 70
Pinealoma 12 73
Malignant Neoplasm of Pineal Gland 70
Malignant Tumor of Pineal Gland 12
Malignant Pineal Region Tumor 12
Neoplasm of the Pineal Region 12
Neoplasm of Pineal Gland 12
Pineal Gland Neoplasm 70
Pineal Body Neoplasm 12
Pineocytic Tumor 12
Pineocytoma 70

Classifications:



External Ids:

Disease Ontology 12 DOID:5032
ICD9CM 34 194.4
MeSH 44 D010871
SNOMED-CT 67 127026004 93962006
ICD10 32 C75.3
UMLS 70 C0031941 C0153655 C0917890 more

Summaries for Pineal Gland Cancer

Disease Ontology : 12 An endocrine gland located in the pineal gland located in the brain.

MalaCards based summary : Pineal Gland Cancer, also known as tumor of the pineal region, is related to papillary tumor of the pineal region and pineocytoma. An important gene associated with Pineal Gland Cancer is SYP (Synaptophysin), and among its related pathways/superpathways are Neuroscience and Neural Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Lenograstim and Sargramostim have been mentioned in the context of this disorder. Affiliated tissues include pineal gland located in the brain, pineal and thyroid.

Wikipedia : 73 A pinealoma is a tumor of the pineal gland, a part of the brain that produces melatonin. If a pinealoma... more...

Related Diseases for Pineal Gland Cancer

Diseases related to Pineal Gland Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 272)
# Related Disease Score Top Affiliating Genes
1 papillary tumor of the pineal region 33.0 SYP ENO2
2 pineocytoma 31.3 SYP SAG GFAP ENO2 ASMT
3 papillary ependymoma 30.8 SYP GFAP
4 atypical teratoid rhabdoid tumor 30.4 SYP SMARCB1 GFAP
5 papilloma of choroid plexus 30.3 SYP SMARCB1 GFAP ENO2
6 hydrocephalus 30.0 SYP SMARCB1 GFAP ENO2
7 thymic carcinoma 29.9 SYP KRT18 ENO2
8 teratoma 29.9 SYP SMARCB1 KRT18 GFAP ENO2 AFP
9 cellular ependymoma 29.9 SYP GFAP
10 rhabdoid meningioma 29.6 SYP SMARCB1 OLIG2 GFAP ENO2
11 retinoblastoma 29.6 SMARCB1 SAG ENO2 CRX ASMT
12 central nervous system cancer 29.6 SYP SMARCB1 OLIG2 GFAP
13 pineoblastoma 29.6 SYP SAG OR4C12 KBTBD4 GFAP FOXR2
14 medulloblastoma 29.5 SYP SMARCB1 SAG GFAP ENO2 DICER1
15 obstructive hydrocephalus 29.5 SYP OLIG2 GFAP ENO2 AFP
16 oligodendroglioma 29.4 SYP OLIG2 GFAP ENO2
17 endodermal sinus tumor 10.5
18 germ cells tumors 10.4
19 rare tumor 10.4
20 malignant melanocytic neoplasm of the peripheral nerve sheath 10.4 SYP ENO2
21 anal neuroendocrine tumor 10.4 SYP ENO2
22 neuronal intestinal dysplasia, type b 10.4 SYP ENO2
23 lung meningioma 10.4 SYP ENO2
24 sinonasal undifferentiated carcinoma 10.4 SYP ENO2
25 auditory system benign neoplasm 10.4 SYP ENO2
26 auditory system cancer 10.4 SYP ENO2
27 cloacogenic carcinoma 10.4 SYP ENO2
28 extraosseous ewings sarcoma-primitive neuroepithelial tumor 10.4 SYP ENO2
29 cauda equina neoplasm 10.4 SYP ENO2
30 intracranial primitive neuroectodermal tumor 10.4 SYP ENO2
31 bile duct mucinous adenocarcinoma 10.4 SYP ENO2
32 extraventricular neurocytoma 10.4 SYP GFAP
33 thymus sarcomatoid carcinoma 10.4 SYP AFP
34 nodular prostate 10.4 SYP ENO2
35 ampulla of vater benign neoplasm 10.4 SYP ENO2
36 appendix carcinoid tumor 10.4 SYP ENO2
37 carotid body cancer 10.4 SYP ENO2
38 gallbladder small cell carcinoma 10.4 SYP ENO2
39 ureter small cell carcinoma 10.4 SYP ENO2
40 cerebellar liponeurocytoma 10.4 SYP ENO2
41 desmoplastic infantile ganglioglioma 10.4 SYP GFAP
42 middle ear adenoma 10.4 SYP ENO2
43 chordoid glioma 10.4 SYP GFAP
44 urinary bladder small cell neuroendocrine carcinoma 10.4 SYP ENO2
45 gastric small cell carcinoma 10.4 SYP ENO2
46 extracranial neuroblastoma 10.4 SYP ENO2
47 jejunal neoplasm 10.4 SYP ENO2
48 lung combined type small cell carcinoma 10.4 SYP GFAP
49 frontal lobe neoplasm 10.4 SYP ENO2
50 rectum neuroendocrine neoplasm 10.4 SYP AFP

Comorbidity relations with Pineal Gland Cancer via Phenotypic Disease Network (PDN):


Obstructive Hydrocephalus

Graphical network of the top 20 diseases related to Pineal Gland Cancer:



Diseases related to Pineal Gland Cancer

Symptoms & Phenotypes for Pineal Gland Cancer

Drugs & Therapeutics for Pineal Gland Cancer

Drugs for Pineal Gland Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 108)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lenograstim Approved, Investigational Phase 3 135968-09-1
2
Sargramostim Approved, Investigational Phase 3 123774-72-1, 83869-56-1
3 Immunologic Factors Phase 3
4 Adjuvants, Immunologic Phase 3
5
Clotrimazole Approved, Vet_approved Phase 2 23593-75-1 2812
6
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
7
Sirolimus Approved, Investigational Phase 2 53123-88-9 6436030 5284616
8
Ethanol Approved Phase 2 64-17-5 702
9
Sorbitol Approved Phase 2 50-70-4 5780
10
tannic acid Approved Phase 2 1401-55-4
11
Titanium dioxide Approved Phase 2 13463-67-7
12
Dasatinib Approved, Investigational Phase 2 302962-49-8 3062316
13
Benzocaine Approved, Investigational Phase 2 1994-09-7, 94-09-7 2337
14
Temozolomide Approved, Investigational Phase 2 85622-93-1 5394
15
Bevacizumab Approved, Investigational Phase 2 216974-75-3
16
Irinotecan Approved, Investigational Phase 2 100286-90-6, 97682-44-5 60838
17
Vitamin C Approved, Nutraceutical Phase 2 50-81-7 5785 54670067
18
Camptothecin Experimental Phase 2 7689-03-4
19
MK-1775 Investigational Phase 1, Phase 2 955365-80-7, 501-36-0 24856436 445154
20 Anti-Retroviral Agents Phase 1, Phase 2
21 Plerixafor octahydrochloride Phase 1, Phase 2
22 Anti-HIV Agents Phase 1, Phase 2
23 Protein Kinase Inhibitors Phase 2
24 Antibiotics, Antitubercular Phase 2
25 Anti-Bacterial Agents Phase 2
26 Anti-Infective Agents Phase 2
27 Antifungal Agents Phase 2
28 Pharmaceutical Solutions Phase 2
29 Soy Bean Phase 2
30 Carboxymethylcellulose Sodium Phase 2
31 Alkylating Agents Phase 2
32 Angiogenesis Inhibitors Phase 2
33 Antineoplastic Agents, Immunological Phase 2
34 Immunoglobulins, Intravenous Phase 2
35 topoisomerase I inhibitors Phase 2
36 Immunoglobulin G Phase 2
37 Endothelial Growth Factors Phase 2
38
Lenalidomide Approved Phase 1 191732-72-6 216326
39
Bortezomib Approved, Investigational Phase 1 179324-69-7 93860 387447
40
Gemcitabine Approved Phase 1 95058-81-4 60750
41
Trametinib Approved Phase 1 871700-17-3 11707110
42
Vorinostat Approved, Investigational Phase 1 149647-78-9 5311
43
Etoposide Approved Phase 1 33419-42-0 36462
44
Melphalan Approved Phase 1 148-82-3 4053 460612
45
Thiotepa Approved, Investigational Phase 1 52-24-4 5453
46
Cyclophosphamide Approved, Investigational Phase 1 50-18-0, 6055-19-2 2907
47
Carboplatin Approved Phase 1 41575-94-4 10339178 498142 38904
48
Cisplatin Approved Phase 1 15663-27-1 84093 441203 2767
49
Vincristine Approved, Investigational Phase 1 2068-78-2, 57-22-7 5978
50
Isotretinoin Approved Phase 1 4759-48-2 5282379 5538

Interventional clinical trials:

(show all 41)
# Name Status NCT ID Phase Drugs
1 Prospective and Randomized Study of Fixed Versus Flexible Prophylactic Administration of Granulocyte Colony-Stimulating Factor (G-CSF) in Children With Cancer Terminated NCT01987596 Phase 3
2 Phase II Prospective Study of Sequential Myeloablative Chemotherapy With Stem Cell Rescue for the Treatment of Selected High Risk CNS Tumors and Recurrent CNS Tumors Completed NCT00179803 Phase 2
3 A Randomized Phase II Trial of Bevacizumab to Control Brain Radiation Damage Completed NCT00492089 Phase 2 bevacizumab;placebo
4 A Phase I/II Study of Local Field Irradiation and Temozolomide Followed by Continuous Infusion Plerixafor as an Upfront Therapy for Newly Diagnosed Glioblastoma GBM Completed NCT01977677 Phase 1, Phase 2 temozolomide;plerixafor
5 Proton Radiation for Low Grade Gliomas Completed NCT01024907 Phase 1, Phase 2
6 Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma Recruiting NCT02596828 Phase 2 Temozolomide;Irinotecan;Dasatinib;Rapamycin
7 Temozolomide With Irinotecan Versus Temozolomide, Irinotecan Plus Bevacizumab (NSC# 704865) for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, a COG Randomized Phase II Screening Trial Active, not recruiting NCT01217437 Phase 2 Irinotecan Hydrochloride;Temozolomide
8 A Phase 1/2 Study of AZD1775 (MK-1775) in Combination With Oral Irinotecan in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Tumors Active, not recruiting NCT02095132 Phase 1, Phase 2 Adavosertib;Irinotecan Hydrochloride
9 A Phase 2 Study of Fluorescence Detection of Adult Primary Central Nervous System Tumors in Subjects Receiving Tozuleristide and Imaged With the Canvas System Not yet recruiting NCT04743310 Phase 2 tozuleristide
10 A Phase I Study of SAHA and Temozolomide in Children With Relapsed or Refractory Primary Brain or Spinal Cord Tumors Completed NCT01076530 Phase 1 vorinostat;temozolomide
11 A Phase I Clinical Trial of AZD2171 in Children With Recurrent or Progressive Central Nervous System (CNS) Tumors Completed NCT00326664 Phase 1 Cediranib Maleate
12 A Phase I Trial of CC-5013 (Lenalidomide) in Pediatric Patients With Recurrent or Refractory Primary CNS Tumors Completed NCT00100880 Phase 1 lenalidomide
13 Phase I Trial of Temozolomide and O6-Benzylguanine in Pediatric Patients With Recurrent Brain Tumors Completed NCT00052780 Phase 1 O6-benzylguanine;temozolomide
14 Phase I Pilot Study of Stereotaxic Radiosurgery in Patients With Intracranial Neoplasms Completed NCT00019578 Phase 1
15 Phase 1 Trial of RO4929097 in Combination With Standard Radiotherapy and Temozolomide for Newly Diagnosed Malignant Glioma: A Pharmacokinetic and Pharmacodynamic Study Completed NCT01119599 Phase 1 Gamma-Secretase Inhibitor RO4929097;Temozolomide
16 Phase I Study of Cilengitide (EMD 121974) in Children With Refractory Brain Tumors Completed NCT00063973 Phase 1 cilengitide
17 A Phase I Study of ABT-888, an Oral Inhibitor of Poly (ADP-Ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors Completed NCT00946335 Phase 1 veliparib;temozolomide
18 A Phase I Study of Vorinostat and Bortezomib in Children With Refractory or Recurrent Solid Tumors, Including CNS Tumors and Lymphomas Completed NCT00994500 Phase 1 vorinostat;bortezomib
19 Phase 1 Study of EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric Central Nervous System Tumors Recruiting NCT03638167 Phase 1
20 A First-in-human Phase I Single-agent Dose-escalation, Food Effect and Dose Expansion Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms Recruiting NCT04541082 Phase 1 ONC206
21 Phase 1 Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors Recruiting NCT04185038 Phase 1
22 Phase 1 Study of HER2-Specific CAR T Cell Locoregional Immunotherapy for HER2 Positive Recurrent/Refractory Pediatric Central Nervous System Tumors Recruiting NCT03500991 Phase 1
23 Molecularly-Driven Doublet Therapy for All Children With Refractory or Recurrent CNS Malignant Neoplasms and Young Adults With Refractory or Recurrent SHH Medulloblastoma Recruiting NCT03434262 Phase 1 Gemcitabine;ribociclib;sonidegib;trametinib
24 A Phase 1 Study of Entinostat, an Oral Histone Deacetylase Inhibitor, in Pediatric Patients With Recurrent or Refractory Solid Tumors, Including CNS Tumors and Lymphoma Active, not recruiting NCT02780804 Phase 1 Entinostat
25 A Feasibility Study of Vorinostat (SAHA) Combined With Isotretinoin and Chemotherapy in Infants With Embryonal Tumors of the Central Nervous System Active, not recruiting NCT00867178 Phase 1 Carboplatin;Cisplatin;Cyclophosphamide;Etoposide Phosphate;Isotretinoin;Thiotepa;Vincristine Sulfate;Vorinostat
26 Pilot Study of High-Dose Chemotherapy With Busulfan, Melphalan, and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplant in Advanced Stage and Recurrent Tumors Active, not recruiting NCT00638898 Phase 1 busulfan;melphalan;topotecan hydrochloride
27 Microenvironment: Imaging/Implications in Brain Tumors; A Preliminary Investigation of the Biodistribution of [F-18]-EF5 in Patients With Brain Tumors Terminated NCT00110032 Phase 1 EF5
28 Phase I Study of CDK 4-6 Inhibitor PD-0332991 (Palbociclib; IBRANCE) in Children With Recurrent, Progressive or Refractory Central Nervous System Tumors Terminated NCT02255461 Phase 1 palbociclib isethionate
29 A PHASE 1/2 STUDY OF RO4929097, AN ORAL SMALL MOLECULE INHIBITOR OF GAMMA-SECRETASE, IN CHILDREN WITH RELAPSED/REFRACTORY SOLID OR CNS TUMORS, LYMPHOMA, OR T-CELL LEUKEMIA Terminated NCT01088763 Phase 1 gamma-secretase/Notch signalling pathway inhibitor RO4929097;dexamethasone
30 A Phase I Study of IMC-A12 (Anti-Insulin-like Growth Factor-I Receptor Monoclonal Antibody) in Combination With CCI-779 (Temsirolimus) in Pediatric Patients With Recurrent or Refractory Solid Tumors Withdrawn NCT01182883 Phase 1 IMC-A12;Temsirolimus
31 A Pilot Study of StrataXRT, a Topical Silicone Barrier, to Prevent Auricular Radiation Dermatitis in Pediatric Patients Undergoing Proton Cerebrospinal Radiation Therapy Withdrawn NCT03990597 Phase 1 Wound Dressing Material
32 Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging Completed NCT01884194
33 Melatonin Replacement Therapy Effects on Cardiac Autonomic Activity in Pinealectomized Patients Completed NCT03885258 Early Phase 1 Melatonin Replacement Therapy
34 International Pleuropulmonary Blastoma Registry for PPB, DICER1 and Associated Conditions Recruiting NCT03382158
35 Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma: An Assessment of Acute Toxicity and Long Term Neurocognitive, Neuroendocrine and Ototoxicity Outcomes Active, not recruiting NCT01063114
36 Phase II Study of Craniospinal and Posterior Fossa Irradiation Using Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma: Assessment of Acute and Long Term Sequelae Active, not recruiting NCT00105560
37 Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome Active, not recruiting NCT00565903
38 Dynamic Contrast Enhanced Steady State T1-Weighted Perfusion MRI (DCE MRI): Characterization of Intracranial Lesions Terminated NCT02967380 Gadobenate Dimeglumine;Gadobutrol
39 Yoga and Brain Cancer: A Feasibility Study Terminated NCT01234805
40 A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research Purposes Terminated NCT01251913
41 Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors Withdrawn NCT02194452

Search NIH Clinical Center for Pineal Gland Cancer

Genetic Tests for Pineal Gland Cancer

Anatomical Context for Pineal Gland Cancer

The Foundational Model of Anatomy Ontology organs/tissues related to Pineal Gland Cancer:

19
Pineal Gland Located In The Brain

MalaCards organs/tissues related to Pineal Gland Cancer:

40
Pineal, Thyroid, Brain, Spinal Cord, Endothelial, Pituitary

Publications for Pineal Gland Cancer

Articles related to Pineal Gland Cancer:

(show top 50) (show all 133)
# Title Authors PMID Year
1
PTEN R130Q Papillary Tumor of the Pineal Region (PTPR) with Chromosome 10 Loss Successfully Treated with Everolimus: A Case Report. 61
33804593 2021
2
Papillary tumor of the pineal region in pediatric populations: An additional case and systematic review of a rare tumor entity. 61
33360024 2021
3
Papillary tumor of the pineal region: a single-center experience. 61
33133629 2020
4
Radiotherapy for papillary tumor of the pineal region: A systematic review of the literature. 61
31896492 2020
5
Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations. 61
31768671 2020
6
Molecular characterization of histopathological ependymoma variants. 61
31679042 2020
7
Increased VEGF levels in a case of papillary tumor of the pineal region with intracranial hemorrhage: a potential surrogate indicator of tumor angiogenesis and aggressiveness? 61
26745494 2020
8
Papillary Tumor of the Pineal Region with Parinaud Syndrome: A Case Report. 61
33081665 2020
9
Papillary Tumor of the Pineal Region: Systematic Review and Analysis of Prognostic Factors. 61
30989225 2019
10
Solitary fibrous tumor of the pineal region with delayed ectopic intracranial metastasis: A case report and review of the literature. 61
31124953 2019
11
Primary pineal tumors - Unraveling histological challenges and certain clinical myths. 61
31085866 2019
12
Papillary Ependymoma of the Spinal Cord: A Case Report with Summary of Prior Published Cases. 61
30937039 2019
13
Papillary tumor of the pineal region: Case report and review of the literature. 61
29691144 2019
14
Durable response to mTOR inhibition in a patient with relapsing papillary tumor of the pineal region. 61
30295836 2019
15
Recurrent Pineocytomalike Papillary Tumor of The Pineal Region: A Case Report and Literature Review. 61
30165231 2018
16
Microsurgical Resection of Posterior Third Ventricular/Pineal Region Papillary Tumor Via Supracerebellar Infratentorial Approach: 3-Dimensional Operative Video. 61
29788336 2018
17
Papillary Tumor of the Pineal Region in Children: Presentation of a Case and Comprehensive Literature Review. 61
29906576 2018
18
Primary Intracranial Manifestation of a Carcinosarcoma. 61
30283584 2018
19
Masson's tumor of the pineal region: case report. 61
28777021 2018
20
Papillary tumor of the pineal region accompanied by Parinaud's syndrome: magnetic resonance imaging findings. 61
29991845 2018
21
Unedited microneurosurgery of a mixed germ cell tumor of the pineal region. 61
30687573 2018
22
Unedited microneurosurgery of a large recurrent papillary tumor of the pineal region. 61
30595955 2018
23
One burr-hole craniotomy: Posterior interhemispheric approach in Helsinki Neurosurgery. 61
30283716 2018
24
Unedited microneurosurgery of a solitary fibrous tumor of the pineal region. 61
30595953 2018
25
A Case of Nongerminomatous Germ Cell Tumor of the Pineal Region: Risks and Advantages of Biopsy by Endoscopic Approach. 61
29713348 2018
26
Histology-Stratified Tumor Control and Patient Survival After Stereotactic Radiosurgery for Pineal Region Tumors: A Report From the International Gamma Knife Research Foundation. 61
28751141 2017
27
Nuclear CRX and FOXJ1 Expression Differentiates Non-Germ Cell Pineal Region Tumors and Supports the Ependymal Differentiation of Papillary Tumor of the Pineal Region. 61
28719464 2017
28
Mixed pineal mature teratoma and germinoma in two brothers of the fraternal triplets. 61
28236067 2017
29
Supraorbital subfrontal trans-laminar endoscope-assisted approach for tumors of the posterior third ventricle. 61
28236180 2017
30
The Role of Adjuvant Radiotherapy in the Treatment of Papillary Tumors of the Pineal Region: Some General Considerations and a Case Report. 61
29271218 2017
31
Atypical Teratoid/Rhabdoid Tumor of the Pineal Region in a Young Adult Male Patient: Case Report and Review of the Literature. 61
27144539 2017
32
Long-term follow-up of a papillary tumor of the pineal region: addendum to a case report. 61
27568037 2016
33
Cytologic features of papillary tumor of the pineal region: A case report showing tigroid background. 61
27535020 2016
34
A case of papillary tumor of the pineal region with a long clinical history: molecular characterization and therapeutic consideration with review of the literature. 61
27472995 2016
35
Papillary Tumor of the Pineal Region: A Distinct Molecular Entity. 61
26113311 2016
36
Papillary tumor of pineal region with an unusual clinical presentation: Case report and review of the literature. 61
26889301 2016
37
Late dissemination via cerebrospinal fluid of papillary tumor of the pineal region: a case report and literature review. 61
27179224 2016
38
Papillary tumor of the pineal region: A case report and review of the literature. 61
26622493 2015
39
Lack of BRAF-V600E Mutation in Papillary Tumor of the Pineal Region. 61
26125673 2015
40
Papillary tumor of the pineal region presenting with Foster Kennedy sign. 61
26183673 2015
41
Papillary tumor of the pineal region with synchronous suprasellar focus and novel cytogenetic features. 61
26068071 2015
42
Outcomes After Surgery and Radiotherapy for Papillary Tumor of the Pineal Region. 61
25749579 2015
43
Papillary tumor of the pineal region-report of three cases with literature review. 61
26238893 2015
44
Papillary tumor of the pineal region: Histopathological characterization and review of the literature. 61
24556386 2015
45
Papillary tumor of the pineal region with extended clinical and radiologic follow-up. 61
26539320 2015
46
Papillary Tumor of the Pineal Region: MR Signal Intensity Correlated to Histopathology. 61
25688307 2015
47
Papillary tumor of the pineal region. Report of two cases and literature review. 61
25440015 2014
48
Papillary tumor of the pineal region with anaplastic small cell component. 61
23817812 2013
49
Cellular pleomorphism in papillary tumors of the pineal region. 61
22622671 2013
50
Role of surgery, radiotherapy and chemotherapy in papillary tumors of the pineal region: a multicenter study. 61
23314823 2013

Variations for Pineal Gland Cancer

Expression for Pineal Gland Cancer

Search GEO for disease gene expression data for Pineal Gland Cancer.

Pathways for Pineal Gland Cancer

Pathways related to Pineal Gland Cancer according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.99 SYP SAG GFAP ENO2
2 10.7 SYP OLIG2 GFAP
3
Show member pathways
10.16 DROSHA DICER1

GO Terms for Pineal Gland Cancer

Biological processes related to Pineal Gland Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 miRNA metabolic process GO:0010586 9.16 DROSHA DICER1
2 pre-miRNA processing GO:0031054 8.96 DROSHA DICER1
3 production of siRNA involved in RNA interference GO:0030422 8.62 DROSHA DICER1

Molecular functions related to Pineal Gland Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 ribonuclease III activity GO:0004525 8.62 DROSHA DICER1

Sources for Pineal Gland Cancer

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....